|
| |
 |
 |
 |
| |
| What sets
Pipeline apart? |
 |
Free, unlimited research support from expert analysts
|
|
Simple, user-friendly interface |
| |
Web-based access, available to all employees |
|
Unrivalled, market-leading coverage |
|
Free, unlimited training |
|
|
 |
|
 |
|
| |
|
| |
|
|
| |
 What is Pipeline’s research support?
Sometimes you just don't have time to track down that elusive piece of information – maybe you've heard a rumour that a drug has been discontinued, or you need confirmation of a drug's mechanism of action? Whatever your drug information needs, Pipeline's Research Support service gives you unlimited, direct access to our team of analysts. They will track down the information you are looking for and will dedicate up to 3 hours of their time to every enquiry.
All new information we uncover is added to Pipeline for the benefit of all subscribers. So if your competitors' ask our analysts to perform research that results in new, exclusive information being added to Pipeline, you'll benefit from it too!
There are no additional fees or costs to your organization to use Pipeline's Research Support.
|
|
| |
|
|
| |
Accessing Pipeline’s research support
Access to Pipeline's Research Support is integrated within the Pipeline interface. To contact our analysts you simply click on the Research Support button and submit your request via email. When we receive your request, our analysts scan our entire information universe and, if appropriate, contact the relevant companies to uncover or confirm the information you need. You will receive an immediate confirmation of request and will hear back from a Pipeline Analyst within one business day.
|
|
| |
|
|
| |
Actual
research support
requests
Clients use Pipeline’s Research Support service to gather deeper drug-specific
intelligence. Here we provide a sample of the types of requests we answer on
a daily basis for our clients.
|
|
| |
| |
Drug Information
Do you have any update on the mechanism of action of LabCode-123? I have heard that it may be an Enzyme-X inhibitor.
I am trying to find out if PharmaCo's TARGET-1 antagonist is an NCE or a MAb. Can you find any further information?
Could you confirm whether PharmaCo's anthrax vaccine is a recombinant or synthetic peptide? |
Development Status Information
Could you find out why Drug X was discontinued at Phase III?
I understand that Drug Y is due to enter Phase III next year. Do you know when PharmaCo intends to file for approval in the US?
Is Drug X commercialized for asthma, or has development ceased? There seems to be very little information available in the public domain beyond 2005. |
Company/Marketing/Licensing
Information
Has BiotechCo exercised its development option for PharmaCo's Drug X project?
Has Drug Y been launched yet in Israel?
Is Drug Z available for licensing in the US? |
Clinical Information
I notice that enrolment has been suspended in all Phase II trials while Drug X undergoes reformulation. Can you find out when trials are likely to resume?
When is Phase III development expected to start for Drug Y? What is expected to be the lead indication?
I see that Drug Z is in Phase II trials for rheumatoid arthritis. Are Phase II trials in osteoarthritis also planned? |
Confirmation of Rumoured Drug Information
I have heard that PharmaCo may be studying TARGET-3 antagonists, possibly for COPD. Can you find any evidence for this?
Following the recent much-publicized withdrawal of PharmaCo's FamousDrug from the US market for safety reasons, I have just heard on the grapevine that OtherPharma's Phase III trials of SimilarDrug have been put on hold. Could you check this out for me
To maintain client confidentiality, the names of drugs, companies, trials and some other details have been masked.
|
To maintain client confidentiality, the names of drugs, companies, trials and some other details have been masked. |
|
|
| |
|
|
|
| |
| |
|
